The Natural Anticancer Compounds Rocaglamides Inhibit the Raf-MEK-ERK Pathway by Targeting Prohibitin 1 and 2Gernot Polier, Min Li‐Weber, Rebecca Köhler et al.|Chemistry & Biology|2012Cited by 162
The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen‐activated protein kinase activitiesJia Zhu, Min Li‐Weber, Inna N. Lavrik et al.|International Journal of Cancer|2007Cited by 96
Rocaglamide Derivatives Are Immunosuppressive Phytochemicals That Target NF-AT Activity in T CellsPeter Proksch, Min Li‐Weber, Marco Giaisi et al.|The Journal of Immunology|2005Cited by 74
Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expressionMarc Bleumink, Rebecca Köhler, Marco Giaisi et al.|Cell Death and Differentiation|2010Cited by 69